乐普生物2022年上半年聚焦核心管线开发,加速商业化落地 Aug 25, 2022 17:46 HKT | ![Lepu](http://www.acnnewswire.com/images/toppage/LepuBio_Top.jpg) |
|
樂普生物2022年上半年聚焦核心管線開發,加速商業化落地 Aug 25, 2022 17:45 HKT | ![Lepu](http://www.acnnewswire.com/images/toppage/LepuBio_Top.jpg) |
|
兆科眼科公布2022中期业绩 Aug 24, 2022 20:39 HKT | ![Zhaoke](http://www.acnnewswire.com/images/toppage/Zhaoke_Top.jpg) |
|
兆科眼科公佈2022中期業績 Aug 24, 2022 20:38 HKT | ![Zhaoke](http://www.acnnewswire.com/images/toppage/Zhaoke_Top.jpg) |
|
Zhaoke Ophthalmology Announces 2022 Interim Results Aug 24, 2022 20:37 HKT | ![Zhaoke](http://www.acnnewswire.com/images/toppage/Zhaoke_Top.jpg) |
|
重磅 深睿医疗6大创新任务荣登工信部、药监局揭榜名单 Aug 24, 2022 12:52 HKT | |
|
重磅 深睿醫療6大創新任務榮登工信部、藥監局揭榜名單 Aug 24, 2022 12:51 HKT | |
|
中国抗体宣布SN1011针对视神经脊髓炎谱系疾病的新药研究申请获国家药监局批准 Aug 24, 2022 08:07 HKT | ![SinoMab](http://www.acnnewswire.com/images/toppage/SinoMab_Top.jpg) |
|
中國抗體宣佈SN1011針對視神經脊髓炎譜系疾病的新藥研究申請獲國家藥監局批准 Aug 24, 2022 08:06 HKT | ![SinoMab](http://www.acnnewswire.com/images/toppage/SinoMab_Top.jpg) |
|
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA Aug 24, 2022 08:05 HKT | ![SinoMab](http://www.acnnewswire.com/images/toppage/SinoMab_Top.jpg) |
|
Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore Aug 24, 2022 07:55 HKT | ![Avantor](http://www.acnnewswire.com/images/toppage/avantor.logo.68.jpg) |
|
Oculis公佈II期數據抗腫瘤壞死因子(anti-TNFa)眼藥滴劑利卡明利單抗(OCS-02)可緩解嚴重干眼病患者的持續眼部不適 Aug 23, 2022 20:38 HKT | ![Oculis](http://www.acnnewswire.com/images/toppage/Oculis_Top.jpg) |
|
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease Aug 23, 2022 20:37 HKT | ![Oculis](http://www.acnnewswire.com/images/toppage/Oculis_Top.jpg) |
|
中国生物制药(1177.HK)公布2022年中期业绩,收入上升5.9%至人民币151.94亿元 Aug 23, 2022 19:53 HKT | ![Sino](http://www.acnnewswire.com/images/toppage/SinoBio_Top.jpg) |
|
中國生物製藥(1177.HK)公布2022年中期業績,收入上升5.9%至人民幣151.94億元 Aug 23, 2022 19:52 HKT | ![Sino](http://www.acnnewswire.com/images/toppage/SinoBio_Top.jpg) |
|
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion Aug 23, 2022 19:51 HKT | ![Sino](http://www.acnnewswire.com/images/toppage/SinoBio_Top.jpg) |
|
Sirnaomics获纳入恒生指数系列成份股 Aug 22, 2022 09:49 HKT | |
|
Sirnaomics獲納入恒生指數系列成份股 Aug 22, 2022 09:48 HKT | |
|
Sirnaomics Becoming A Constituent of Hang Seng Family of Indexes Aug 22, 2022 09:47 HKT | |
|
沛嘉医疗公布2022年中期业绩:TaurusOne(R)及TaurusElite(R)屡创月度植入量新高 Aug 22, 2022 09:31 HKT | ![Peijia](http://www.acnnewswire.com/images/toppage/Peijia.64.jpg) |
|